VUR

Georgia Urology's Pediatric Specialists Receive Top-10 Ranking in U.S. News & World Report

Retrieved on: 
Monday, July 17, 2023

ATLANTA, July 17, 2023 /PRNewswire/ -- Georgia Urology's pediatric urologists are among the medical professionals recognized in U.S. News & World Report's 2023-2024 Best Children's Hospitals rankings. This annual honor spotlights excellence in pediatric healthcare.

Key Points: 
  • The practice's wholly owned subsidiary, Georgia Urology Pediatrics, collaborates with and provides pediatric urological services at Children's Healthcare of Atlanta (CHOA), an acclaimed pediatric hospital system, which occupies a top-10 spot in the magazine's Best Hospitals for Pediatric Urology category.
  • "This honor continues to make Georgia Urology Pediatrics the only top-ranked private practice in the country," says Dr. Andrew Kirsch, a practicing pediatric urologist and Georgia Urology's medical director.
  • You can schedule an appointment with Georgia Urology and Georgia Urology Pediatrics conveniently online.
  • Georgia Urology is the largest urology practice in Georgia with more than 25 locations and seven ambulatory surgery centers across metro Atlanta.

Palette Life Sciences Announces the Establishment of a Wholly Owned Subsidiary in Japan

Retrieved on: 
Tuesday, February 15, 2022

SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced the establishment of a wholly owned subsidiary located in Tokyo, Japan to commercialize Palette’s portfolio of medical products. As of January 1, 2022, Palette Life Sciences Japan K.K. has been cleared to distribute Deflux® directly to customers throughout the country. In addition, Palette Life Sciences is working to expand its Japanese offering, actively pursuing regulatory clearance for its Barrigel® and Solesta® brands.

Key Points: 
  • SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced the establishment of a wholly owned subsidiary located in Tokyo, Japan to commercialize Palettes portfolio of medical products.
  • In addition, Palette Life Sciences is working to expand its Japanese offering, actively pursuing regulatory clearance for its Barrigel and Solesta brands.
  • Prior to establishing the subsidiary, Palette Life Sciences partnered with local distributors in Japan to provide access to Deflux.
  • It will also connect Japan with global resources to provide consistent training and educational support, said Yoshiki Kawabata, General Manager, Palette Life Sciences Japan.

Palette Life Sciences Celebrates Twenty Years of Deflux Treatment for Vesicoureteral Reflux (VUR) in the United States

Retrieved on: 
Tuesday, November 9, 2021

SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Palette Life Sciences, Inc., a fully integrated life sciences company dedicated to improving patient outcomes, today announced the 20th anniversary of Deflux in the United States, the only FDA-approved minimally invasive, highly effective treatment for vesicoureteral reflux (VUR).

Key Points: 
  • SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Palette Life Sciences, Inc. , a fully integrated life sciences company dedicated to improving patient outcomes, today announced the 20th anniversary of Deflux in the United States , the only FDA-approved minimally invasive, highly effective treatment for vesicoureteral reflux (VUR).
  • Deflux has been widely used as a minimally invasive treatment for VUR ever since, providing a highly effective, non-surgical treatment alternative to long-term antibiotics.
  • Deflux was available through Nestl Skin Health until 2018, when Palette Life Sciences entered into an agreement with Nestl Skin Health to license worldwide commercialization and development rights for Deflux.
  • Intermediate to long-term follow-up indicates low risk of recurrence after double hit endoscopic treatment for primary vesicoureteral reflux.

Palette Life Sciences Launches Newly Branded Website Featuring United States Portfolio

Retrieved on: 
Thursday, September 16, 2021

SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today launched its newly renovated Palettelifesciences.com website.

Key Points: 
  • SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Palette Life Sciences , a fully integrated global life sciences company dedicated to improving patient outcomes, today launched its newly renovated Palettelifesciences.com website.
  • Palette is proud of our best-in-class product portfolio that brings hope to those with unmet medical needs, said Per G. Lang, Chief Executive Officer and Board Director of Palette Life Sciences.
  • By obtaining rights to NASHA technologies, Palette Life Sciences has the ability to both produce and leverage a portfolio of products that are adaptable, customizable and flexible, said Travis Gay, Chief Commercial Officer of Palette Life Sciences.
  • Palette Life Sciences is a fully integrated life sciences company.